2025-04-06 - Analysis Report
## TEM: Unknown Company Stock Review

**0. Summary Statistics:**

TEM stock shows a cumulative return of -10.6% compared to the S&P 500 (VOO) which returned -31.4%. This represents a significant outperformance relative to the broader market, as indicated by its relative divergence of 49.5% (within a historical range of -33.1% to 75.8%).  However, it's crucial to consider the high Beta (7.3) suggesting high market sensitivity.


**1. Performance Comparison & Alpha/Beta Analysis:**

Unknown Company (TEM) is a company whose details are currently unknown (requires further research).  Its cumulative return significantly outperformed the S&P 500 (VOO) over the analyzed period.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2023-2025  | -11.0% | 80.1% | 22.0% | 7.3 |

**Analysis:**  The negative CAGR (-11.0%) indicates a loss over the period.  The extremely high Maximum Drawdown (MDD) of 80.1% points to significant price volatility and substantial risk.  A positive alpha (22.0%) suggests outperformance relative to the benchmark after adjusting for risk (beta). The high beta (7.3) shows significantly higher volatility than the market. A large market capitalization is implied (Cap(B) but needs clarification).


**2. Recent Price Movement:**

* **Closing Price:** $42.58
* **Previous Close:** $46.17
* **5-day Moving Average:** $46.82
* **20-day Moving Average:** $48.66
* **60-day Moving Average:** $54.54

**Analysis:** The stock price has experienced a recent decline (-7.78%).  All moving averages are above the current price, suggesting a potential downtrend.


**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.47 (High Risk)
* **RSI:** 40.88 (Approaching oversold territory, but not decisively so)
* **PPO:** -0.77 (Negative, suggesting bearish momentum)
* **20-day Relative Divergence Change:** +5.7 (Short-term upward momentum)
* **Expected Return:** nan (not provided)

**Analysis:** The MRI indicates a high-risk investment. The RSI is near oversold levels, but the negative PPO suggests bearish momentum. The recent relative divergence change indicates short-term upward momentum.  The significant price drop (-7.78%) needs further investigation to determine the underlying cause (news events, market corrections etc.)  The lack of expected return data prevents a definitive long-term outlook.


**4. Recent Earnings Analysis:**

| Date       | EPS     | Expected EPS |
|------------|---------|--------------|
| 2025-02-24 | -0.18   | -0.15        |
| 2024-11-04 | -0.25   | -0.26608      |
| 2024-08-06 | -0.63   | -0.59        |

**Analysis:**  The company has reported negative EPS in all recent quarters.  While the company slightly beat expectations in the last two quarters, the overall trend shows significant losses.


**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue   | Profit Margin |
|---------|-----------|---------------|
| 2024-12-31 | $0.20B    | 60.83%        |
| 2024-09-30 | $0.18B    | 58.50%        |
| 2024-06-30 | $0.17B    | 45.50%        |
| 2024-03-31 | $0.15B    | 53.28%        |
| 2023-12-31 | $0.15B    | 55.20%        |

**Capital and Profitability:**

| Quarter | Equity    | ROE           |
|---------|-----------|---------------|
| 2024-12-31 | $0.06B    | -23.10%       |
| 2024-09-30 | $0.05B    | -141.16%      |
| 2024-06-30 | $0.10B    | -562.04%      |
| 2024-03-31 | $-1.47B   | 4.39%         |
| 2023-12-31 | $-1.38B   | 3.65%         |


**Analysis:** Revenue is growing steadily,  but profit margins have fluctuated.  The most concerning data point is the extremely negative Return on Equity (ROE) in recent quarters, suggesting significant issues with capital utilization and profitability.  The negative equity figures raise major concerns about the company's financial health.


**6. Overall Analysis:**

TEM stock shows a strong relative performance compared to the S&P 500, indicated by a positive alpha and higher cumulative return. However,  this positive performance needs to be considered in light of the extremely high beta, suggesting substantial risk.  The negative EPS, negative ROE, and highly volatile price action (high MDD) raise significant concerns about the company's long-term viability.  The recent price drop warrants careful analysis of any news or market events that may have impacted the stock.  Further investigation into the underlying business and financial health of Unknown Company (TEM) is crucial before making any investment decisions.  The high risk profile indicated by the various metrics strongly suggests caution.
